Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: Keys to the fate of islet β-cells

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 115, Issue 1, 2002, Pages 37-47

  Moustakas, Antonis K ^b   Papadopoulos, George K ^a  

^a Faculty of Agricultural Technology   (Greece)

^b NONE

Author keywords

HLA DQ; HLA DR; Human type 1 diabetes mellitus (T1DM)

Indexed keywords

ANTIGEN; AUTOANTIGEN; CD4 ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLELE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; DENDRITIC CELL; ENDOSOME; GENE LOCUS; GENE SEGREGATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HELPER CELL; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MONOCYTE; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; ANIMAL; CHEMISTRY; GENETICS; HUMAN; IMMUNOLOGY; PANCREAS ISLET; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

ANIMAL; DIABETES MELLITUS, INSULIN-DEPENDENT; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMAN; ISLETS OF LANGERHANS; PROTEIN STRUCTURE, TERTIARY; SUPPORT, NON-U.S. GOV'T; ANIMALS; DIABETES MELLITUS, TYPE 1; HUMANS;

EID: 0036075110     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.10342     Document Type: Review

References (100)

1. Type-1 diabetes-predisposing MHC alleles influence the selection of glutamic acid decarboxylase (GAD) 65-specific T cell in a transgenic model
2. A disease-associated cellular immune response in type 1 diabetes to an immunodominant epitope of insulin
3. Cellular and molecular changes accompanying the progression from insulitis to diabetes
4. High affinity presentation of an autoantigenic peptide in type 1 diabetes by an HLA Class II protein encoded in a haplotype protecting form disease
5. Antibodies to a Mr 64000 islet cell antigen precede the clinical onset of insulin-dependent diabetes
6. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
7. Dendritic cells and the control of immunity
8. Allelic variation in transcription modifies MHC Class II expression and function
9. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies
10. Peripheral blood mononuclear cells of insulin-dependent diabetic patients respond to multiple islet cell proteins
11. Three-dimensional structure of the human Class II histocompatibility antigen HLA-DR1
12. Endosomal proteolysis and MHC Class II function
13. The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC Class II oligomers
14. Association of susceptibility to spontaneous diabetes in rat with genes of major histocompatibility complex
15. Genetic susceptibility in Type I (insulin-dependent) diabetes
16. Structural analysis of two HLA-DR presented autoantigenic epitopes: Crucial role of peripheral but not central peptide residues for T-cell receptor recognition
17. Autoreactive and immunoregulatory T cell subsets in insulin-dependent diabetes mellitus
18. A peptide binding motif for HLA-DQA1*0102/DQB1*0602, the Class II MHC molecule associated with dominant protection in insulin-dependent diabetes mellitus
19. Exceptional stability of the HLA-DQA1*0102/DQB1*0602 αβ protein dimer, the Class II MHC molecule associated with protection from insulin-dependent diabetes mellitus
20. k in complex with a dominant epitope of lysozyme
21. High precursor frequency of human T lymphocytes reactive to HLA-DQ molecules expressed on mouse L cells transfectants
22. The structure of an intermediate in Class II MHC maturation: CLIP bound to HLA-DR3
23. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2)
24. Evidence for a long pre-diabetic period in type I (insulin-dependent) diabetes mellitus
25. Negative association between type 1 diabetes and HLA DQB1*0602-DQA1*0102 is attenuated with age of onset
26. Peripheral tolerance as a multistep mechanism
27. Quantitation of antigen-presenting cell MHC Class II/peptide complexes necessary for T cell stimulation
28. The NOD mouse: Recessive diabetogenic gene in the Major Histocompatibility Complex
29. + T cells undergoing peripheral deletion in response to cross-presentation of self antigen
30. HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigens in humans
31. Inaugural article. How the immune system works to protect the host from infection: A personal view
32. Separate ontogeny of two macrophage-like accessory cell populations in the human fetus
33. Peptide binding to HLA-DPR1: A peptide with most residues substituted to alanine retains MHC binding
34. Genetic predisposition and IDDM in Greece
35. A combination of HLA-DQβ Asp57-negative and HLA-DQα Arg52 confers susceptibility to insulin-dependent diabetes mellitus
36. Preferential presentation of herpes simplex virus T cell antigen by HLA DQA1*0501/DQB1*0201 in comparison to HLA DQA1*0201/DQB1*0201
37. Involvement of both major histocompatibility complex Class II α and β chains in CD4 function indicates a role for ordered oligomerization in T lymphocyte activation
38. + T cell deletion induced by cross-presentation of self antigens and favors autoimmunity
39. HLA-DQ allelic polymorphisms constrain patterns of Class II heterodimer formation
40. HLA-DQ polymorphisms are highly selective for peptide binding interactions
41. HLA-DQB1 codon 57 is critical for peptide binding and recognition
42. Allele-specific motifs characterize HLA-DQ interactions with a diabetes associated peptide derived from glutamic acid decarboxylase
43. HLA-DQ tetramers identify epitope-specific T cells in the peripheral blood of herpes simplex virus type 2-infected individuals: Direct detection of immunodominant antigen-responsive cells
44. Irreversible association of peptides with Class II MHC molecules in living cells
45. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes
46. null NOD mice
47. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified Aβ-chain or normal I-Eα-chain
48. HLA Class II region sequences
49. Monocytes are differentially activated through HLA-DR, -DQ and -DP molecules via mitogen-activated protein kinases
50. Complete sequencing and gene map of a human major histocompatibility complex
51. Mechanisms of tolerance to self
52. NOD to the development of insulitis in non-obese diabetic mice
53. Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent onset Type 1 diabetes mellitus
54. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes
55. SDS stability of HLA-DR1 complexes correlates with burial of hydrophobic residues in pocket 1
56. "Cytoplasmic" islet cell antibodies. Evidence that the target antigen is a sialoglycoconjugate
57. A unified hypothesis for the complex genetics of HLA associations with type 1 diabetes
58. Molecular basis for HLA-DQ associations with IDDM
59. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice
60. Immunology of IDDM
61. Novel structural features of the human histocompatibility molecules HLA-DQ as revealed by modeling based on the published structure of the related molecule HLA-DR1
62. Insulin antibodies in insulin-dependent diabetics before insulin treatment
63. The genetics of type 1 diabetes: HLA-DQ more important than HLA-DR
64. Celiac disease: Interplay between genetics and the environment. Perspectives for a healthy life
65. Relationship of the 37,000 and 40,000-Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512)
66. HLA-D and -DR antigens in genetic analysis of insulin-dependent diabetes mellitus
67. Self antigen presenting cells expressing diabetes associated autoantigens exist in both thymus and peripheral lymphoid organs
68. SYF-PEITHI: Database for MHC ligands and peptide motifs
69. Mutational analysis of critical residues determining antigen presentation and activation of HLA-DQ0602 restricted T cell clones
70. Differential presentation of glutamic acid decarboxylase 65 (GAD65) T cell epitopes among HLA-DRB1*0401-positive individuals
71. T-cell responses to autoantigens in IDDM. The search for the holy grail
72. HLA-DRB1*0403 is associated with dominant protection against IDDM in the general Dutch population and subjects with high-risk heterozygous DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype
73. Polymorphic structural features of modeled HLA-DQ molecules segregate according to susceptibility or resistance to IDDM
74. + T lymphocytes is receptor dependent and HLA-DQ restricted
75. Polymorphic aminoacid variations in HLA-DQ are associated with systemic physical property changes and occurrence of IDDM
76. DR4 subtypes and their molecular properties in a population based study of Swedish childhood diabetes
77. Proliferative responses to selected peptides of IA-2 in identical twins discor dant for type 1 diabetes
78. d complexes reveal that high affinity can be achieved without large anchor residues
79. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases
80. d transgene prevents diabetes in non obese diabetic mice by inducing regulatory T cells
81. k transgenic mice
82. Molecular basis of celiac disease
83. Evidence for a primary association of celiac disease to a particular HLA-DQ αβ heterodimer
84. Regulation of MHC Class II expression by interferon-γ mediated by the trans-activator gene CIITA
85. Crystal structure of the human Class II MHC protein HLA-DR1 complexed with an influenza virus peptide
86. HLA and disease associations: Detecting the strongest association
87. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus
88. β gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus
89. HLA-encoded genetic predisposition in IDDM. DR4 subtypes may be associated with different degrees of protection
90. Serial triggering of many T cell receptors by a few peptide-MHC complexes
91. Unique peptide-binding characteristics of the disease-associated DQ(α1*0501,β1*0201) molecule vs. the non-disease-associated DQ(α1*0201,β1*0202) molecule
92. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin
93. DRB1*0403 protects against IDDM in Caucasians with the high-risk heterozygous DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype
94. The peptide binding motif of the disease-associated HLA-DQ (α1*0501, β1*0201) molecule
95. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model
96. Genetic control of autoimmune diabetes in the NOD mouse
97. CD8 T cell clones from young non-obese diabetic (NOD) mice can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells
98. Identification of an MHC Class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library